Diagnostics & Research
The Diagnostics & Research industry has a total of 49 stocks, with a combined market cap of $741.48 billion, total revenue of $168.34 billion and a weighted average PE ratio of 46.32.
Market Cap
741.48B
Revenue
168.34B
Profits
16.01B
PE Ratio
46.32
Profit Margin
9.51%
Dividend Yield
0.21%
49 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 203.44B | -0.16% | 769,341 | 44.56B |
| 2 | DHR | Danaher Corporation | 151.69B | -0.54% | 994,597 | 24.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 51.56B | 0.33% | 81,551 | 4.30B |
| 4 | A | Agilent Technologies, Inc. | 36.83B | 0.20% | 265,467 | 6.95B |
| 5 | IQV | IQVIA Holdings Inc. | 31.59B | 2.93% | 1,071,429 | 16.31B |
| 6 | MTD | Mettler-Toledo International Inc. | 27.77B | -1.69% | 71,646 | 4.03B |
| 7 | NTRA | Natera, Inc. | 27.32B | 0.22% | 445,910 | 2.12B |
| 8 | LH | Labcorp Holdings Inc. | 22.98B | -0.36% | 97,187 | 13.77B |
| 9 | WAT | Waters Corporation | 22.44B | 0.02% | 97,670 | 3.11B |
| 10 | DGX | Quest Diagnostics Incorporated | 21.25B | -0.64% | 129,244 | 10.85B |
| 11 | EXAS | Exact Sciences Corporation | 19.45B | -0.17% | 823,261 | 3.08B |
| 12 | ILMN | Illumina, Inc. | 18.39B | -9.92% | 1,316,580 | 4.34B |
| 13 | MEDP | Medpace Holdings, Inc. | 15.27B | 0.16% | 101,107 | 2.36B |
| 14 | GH | Guardant Health, Inc. | 12.77B | 0.79% | 392,624 | 902.57M |
| 15 | RVTY | Revvity, Inc. | 11.48B | 1.73% | 256,375 | 2.86B |
| 16 | ICLR | ICON Public Limited Company | 11.26B | 1.44% | 599,989 | 8.10B |
| 17 | QGEN | Qiagen N.V. | 10.55B | -0.10% | 537,149 | 2.09B |
| 18 | CRL | Charles River Laboratories International, Inc. | 9.12B | 0.83% | 261,205 | 4.02B |
| 19 | RDNT | RadNet, Inc. | 5.08B | 1.75% | 186,777 | 1.97B |
| 20 | SHC | Sotera Health Company | 4.98B | 0.75% | 218,815 | 1.15B |
| 21 | GRAL | GRAIL, Inc. | 3.92B | 6.93% | 289,897 | 141.83M |
| 22 | BLLN | BillionToOne, Inc. | 3.91B | 0.31% | 20,988 | 254.14M |
| 23 | TWST | Twist Bioscience Corporation | 2.96B | 2.54% | 238,329 | 391.56M |
| 24 | VCYT | Veracyte, Inc. | 2.81B | 1.89% | 151,620 | 495.14M |
| 25 | WGS | GeneDx Holdings Corp. | 2.42B | -0.36% | 116,693 | 402.19M |
| 26 | NEOG | Neogen Corporation | 2.34B | 1.70% | 427,210 | 880.32M |
| 27 | NEO | NeoGenomics, Inc. | 1.46B | -0.18% | 308,991 | 709.16M |
| 28 | CDNA | CareDx, Inc. | 981.33M | 3.98% | 140,439 | 358.00M |
| 29 | OPK | OPKO Health, Inc. | 951.95M | 0.81% | 781,307 | 642.07M |
| 30 | CSTL | Castle Biosciences, Inc. | 943.23M | -0.26% | 147,805 | 343.53M |
| 31 | FLGT | Fulgent Genetics, Inc. | 724.90M | -1.10% | 69,235 | 315.55M |
| 32 | PSNL | Personalis, Inc. | 701.55M | 6.54% | 431,890 | 69.10M |
| 33 | MYGN | Myriad Genetics, Inc. | 477.25M | 0.39% | 182,878 | 825.30M |
| 34 | BNR | Burning Rock Biotech Limited | 348.95M | 5.85% | 1,653 | 75.75M |
| 35 | PRE | Prenetics Global Limited | 304.09M | 2.03% | 42,148 | 77.08M |
| 36 | IMDX | Insight Molecular Diagnostics Inc. | 189.76M | -1.05% | 8,947 | 4.40M |
| 37 | MDXH | MDxHealth SA | 171.26M | 1.76% | 17,578 | 103.07M |
| 38 | FONR | FONAR Corporation | 121.40M | - | 2,490 | 105.43M |
| 39 | BDSX | Biodesix, Inc. | 83.46M | 5.32% | 25,441 | 80.17M |
| 40 | XGN | Exagen Inc. | 80.91M | 6.25% | 176,861 | 63.60M |
| 41 | PRPO | Precipio, Inc. | 35.30M | -1.08% | 5,745 | 22.80M |
| 42 | NOTV | Inotiv, Inc. | 16.15M | 20.51% | 297,691 | 513.02M |
| 43 | MBAI | Check-Cap Ltd. | 11.52M | 3.97% | 32,474 | - |
| 44 | MYNZ | Mainz Biomed N.V. | 9.20M | 2.53% | 19,928 | 659.94K |
| 45 | ADVB | Advanced Biomed Inc. | 5.67M | -7.45% | 5,311 | - |
| 46 | NDRA | ENDRA Life Sciences Inc. | 4.25M | -3.87% | 1,812 | - |
| 47 | BIAF | bioAffinity Technologies, Inc. | 3.58M | 6.40% | 24,657 | 6.78M |
| 48 | ISPC | iSpecimen Inc. | 3.14M | -6.98% | 16,563,464 | 3.35M |
| 49 | XWEL | XWELL, Inc. | 2.19M | - | 190,581 | 29.52M |